JP2001097841A - Two-layered cosmetic - Google Patents
Two-layered cosmeticInfo
- Publication number
- JP2001097841A JP2001097841A JP27220599A JP27220599A JP2001097841A JP 2001097841 A JP2001097841 A JP 2001097841A JP 27220599 A JP27220599 A JP 27220599A JP 27220599 A JP27220599 A JP 27220599A JP 2001097841 A JP2001097841 A JP 2001097841A
- Authority
- JP
- Japan
- Prior art keywords
- layer
- oil
- sorbitan
- fatty acid
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 44
- -1 fatty acid esters Chemical class 0.000 claims abstract description 34
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 19
- 239000000194 fatty acid Substances 0.000 claims abstract description 19
- 229930195729 fatty acid Natural products 0.000 claims abstract description 19
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229930002875 chlorophyll Natural products 0.000 claims abstract description 7
- 235000019804 chlorophyll Nutrition 0.000 claims abstract description 7
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 claims abstract description 7
- 239000010949 copper Substances 0.000 claims abstract description 7
- 229910052802 copper Inorganic materials 0.000 claims abstract description 7
- 229920001214 Polysorbate 60 Polymers 0.000 claims abstract description 6
- 239000001509 sodium citrate Substances 0.000 claims abstract description 5
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims abstract description 5
- 229920003169 water-soluble polymer Polymers 0.000 claims abstract description 4
- 239000000203 mixture Substances 0.000 claims description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 18
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 abstract description 9
- 150000002148 esters Chemical class 0.000 abstract description 4
- 239000003921 oil Substances 0.000 description 34
- 235000019198 oils Nutrition 0.000 description 34
- 238000000926 separation method Methods 0.000 description 22
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 235000019441 ethanol Nutrition 0.000 description 10
- 235000002639 sodium chloride Nutrition 0.000 description 10
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 9
- 239000007788 liquid Substances 0.000 description 8
- 239000012071 phase Substances 0.000 description 7
- 239000004094 surface-active agent Substances 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 230000001804 emulsifying effect Effects 0.000 description 6
- 239000000839 emulsion Substances 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 239000000230 xanthan gum Substances 0.000 description 6
- 229920001285 xanthan gum Polymers 0.000 description 6
- 229940082509 xanthan gum Drugs 0.000 description 6
- 235000010493 xanthan gum Nutrition 0.000 description 6
- 229920002385 Sodium hyaluronate Polymers 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 239000006210 lotion Substances 0.000 description 5
- 229940010747 sodium hyaluronate Drugs 0.000 description 5
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 5
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- 238000012790 confirmation Methods 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- 239000003906 humectant Substances 0.000 description 4
- 239000010452 phosphate Substances 0.000 description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 239000004215 Carbon black (E152) Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000004147 Sorbitan trioleate Substances 0.000 description 3
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 239000002260 anti-inflammatory agent Substances 0.000 description 3
- 229940121363 anti-inflammatory agent Drugs 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 235000019337 sorbitan trioleate Nutrition 0.000 description 3
- 229960000391 sorbitan trioleate Drugs 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 2
- 240000000912 Macadamia tetraphylla Species 0.000 description 2
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 239000000686 essence Substances 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 2
- 239000003676 hair preparation Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229960002160 maltose Drugs 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 239000010466 nut oil Substances 0.000 description 2
- 229940055726 pantothenic acid Drugs 0.000 description 2
- 235000019161 pantothenic acid Nutrition 0.000 description 2
- 239000011713 pantothenic acid Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- 239000001540 sodium lactate Substances 0.000 description 2
- 235000011088 sodium lactate Nutrition 0.000 description 2
- 229940005581 sodium lactate Drugs 0.000 description 2
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 2
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- WFXHUBZUIFLWCV-UHFFFAOYSA-N (2,2-dimethyl-3-octanoyloxypropyl) octanoate Chemical compound CCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCC WFXHUBZUIFLWCV-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- LGQKSQQRKHFMLI-SJYYZXOBSA-N (2s,3r,4s,5r)-2-[(3r,4r,5r,6r)-4,5,6-trihydroxyoxan-3-yl]oxyoxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)CO[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)OC1 LGQKSQQRKHFMLI-SJYYZXOBSA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- PAFJZWHXMSQJKV-UQZRNVAESA-N (3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol;octadecanoic acid Chemical compound OC[C@@H](O)C1OC[C@H](O)[C@H]1O.OC[C@@H](O)C1OC[C@H](O)[C@H]1O.OC[C@@H](O)C1OC[C@H](O)[C@H]1O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O PAFJZWHXMSQJKV-UQZRNVAESA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- WAYINTBTZWQNSN-UHFFFAOYSA-N 11-methyldodecyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCCCCCCOC(=O)CC(C)CC(C)(C)C WAYINTBTZWQNSN-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- DHGBAFGZLVRESL-UHFFFAOYSA-N 14-methylpentadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C DHGBAFGZLVRESL-UHFFFAOYSA-N 0.000 description 1
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 1
- VRBHTEGUHVNKEA-UHFFFAOYSA-N 16-methylheptadecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC(C)C VRBHTEGUHVNKEA-UHFFFAOYSA-N 0.000 description 1
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 1
- XFBOJHLYDJZYSP-UHFFFAOYSA-N 2,8-dioxoadenine Chemical compound N1C(=O)N=C2NC(=O)NC2=C1N XFBOJHLYDJZYSP-UHFFFAOYSA-N 0.000 description 1
- UXFQFBNBSPQBJW-UHFFFAOYSA-N 2-amino-2-methylpropane-1,3-diol Chemical compound OCC(N)(C)CO UXFQFBNBSPQBJW-UHFFFAOYSA-N 0.000 description 1
- QNJOVLAFLJQFBF-UHFFFAOYSA-N 2-octyldodecyl 16-methylheptadecanoate Chemical compound CCCCCCCCCCC(CCCCCCCC)COC(=O)CCCCCCCCCCCCCCC(C)C QNJOVLAFLJQFBF-UHFFFAOYSA-N 0.000 description 1
- ZIIVEKCKOPDBLT-UHFFFAOYSA-N 2-octyldodecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCC(COC(=O)C(C)O)CCCCCCCC ZIIVEKCKOPDBLT-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- LGQKSQQRKHFMLI-UHFFFAOYSA-N 4-O-beta-D-xylopyranosyl-beta-D-xylopyranose Natural products OC1C(O)C(O)COC1OC1C(O)C(O)C(O)OC1 LGQKSQQRKHFMLI-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- SQNRKWHRVIAKLP-UHFFFAOYSA-N D-xylobiose Natural products O=CC(O)C(O)C(CO)OC1OCC(O)C(O)C1O SQNRKWHRVIAKLP-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical class OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 244000111489 Gardenia augusta Species 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 235000019487 Hazelnut oil Nutrition 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 241001647091 Saxifraga granulata Species 0.000 description 1
- 206010040830 Skin discomfort Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 241000120569 Streptococcus equi subsp. zooepidemicus Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 240000002299 Symphytum officinale Species 0.000 description 1
- 235000005865 Symphytum officinale Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- NCHJGQKLPRTMAO-XWVZOOPGSA-N [(2R)-2-[(2R,3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NCHJGQKLPRTMAO-XWVZOOPGSA-N 0.000 description 1
- IJCWFDPJFXGQBN-RYNSOKOISA-N [(2R)-2-[(2R,3R,4S)-4-hydroxy-3-octadecanoyloxyoxolan-2-yl]-2-octadecanoyloxyethyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCCCCCCCCCCCC IJCWFDPJFXGQBN-RYNSOKOISA-N 0.000 description 1
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 229940066595 beta tocopherol Drugs 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229940105847 calamine Drugs 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 235000012730 carminic acid Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 239000010628 chamomile oil Substances 0.000 description 1
- 229940072104 cholesteryl hydroxystearate Drugs 0.000 description 1
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- HWDGVJUIHRPKFR-UHFFFAOYSA-I copper;trisodium;18-(2-carboxylatoethyl)-20-(carboxylatomethyl)-12-ethenyl-7-ethyl-3,8,13,17-tetramethyl-17,18-dihydroporphyrin-21,23-diide-2-carboxylate Chemical compound [Na+].[Na+].[Na+].[Cu+2].N1=C(C(CC([O-])=O)=C2C(C(C)C(C=C3C(=C(C=C)C(=C4)[N-]3)C)=N2)CCC([O-])=O)C(=C([O-])[O-])C(C)=C1C=C1C(CC)=C(C)C4=N1 HWDGVJUIHRPKFR-UHFFFAOYSA-I 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 239000001056 green pigment Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 239000010468 hazelnut oil Substances 0.000 description 1
- 229910052864 hemimorphite Inorganic materials 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- 229940093629 isopropyl isostearate Drugs 0.000 description 1
- 229940060384 isostearyl isostearate Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 125000005474 octanoate group Chemical group 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940077397 octyldodecyl lactate Drugs 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- NEOZOXKVMDBOSG-UHFFFAOYSA-N propan-2-yl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C NEOZOXKVMDBOSG-UHFFFAOYSA-N 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 239000010667 rosehip oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229940079841 sodium copper chlorophyllin Drugs 0.000 description 1
- 235000013758 sodium copper chlorophyllin Nutrition 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 239000001570 sorbitan monopalmitate Substances 0.000 description 1
- 235000011071 sorbitan monopalmitate Nutrition 0.000 description 1
- 229940031953 sorbitan monopalmitate Drugs 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 239000001589 sorbitan tristearate Substances 0.000 description 1
- 235000011078 sorbitan tristearate Nutrition 0.000 description 1
- 229960004129 sorbitan tristearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000001430 tilia cordata extract Substances 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 229940118594 trimethylolpropane triisostearate Drugs 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 235000014692 zinc oxide Nutrition 0.000 description 1
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
- 239000011590 β-tocopherol Substances 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、エタノール、イソ
プロピルアルコール等の低級アルコールを含まない二層
型化粧料に関し、詳しくは、静置しておくと水層と油層
の二層に明確に分離するという外観、及び使用時に軽く
振とうすると二層が容易に混ざり合い乳液状となって、
皮膚に極めて良好な感触を与える二層型化粧料に関す
る。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a two-layer cosmetic containing no lower alcohols such as ethanol and isopropyl alcohol, and more specifically, when left at rest, clearly separates into an aqueous layer and an oil layer. Appearance, and when shaking lightly during use, the two layers mix easily and become an emulsion,
The present invention relates to a two-layer cosmetic which gives the skin a very good feel.
【0002】[0002]
【従来の技術】二層型化粧料としては、水層−油層から
なる液−液系のもの、及びカーマイン(カラミン)ロー
ションのような水層−粉体からなる液−固系のものがよ
く知られている。二層型化粧料は、機能を向上させるた
め、必須成分としてアルコール、界面活性剤等を配合す
ることが古くから提案されている。例えば、ピロリドン
カルボン酸ナトリウム、エチルアルコール及び/又はプ
ロピルアルコール、界面活性剤を含有した多層型化粧料
(特公昭52‐28851)、乳酸ナトリウム、エチル
アルコール及び/又はプロピルアルコール、界面活性剤
を含有した多層型化粧料(特開昭54−41335)、
界面活性剤、油剤、水溶性塩又は有機酸、低級アルコー
ル、水を含有した多層型液体化粧料(特開昭64−40
413)、常温で液状の油剤と非イオン型界面活性剤を
含有し、上層が乳化層(特開平4−112811)等が
開示されている。2. Description of the Related Art As a two-layer cosmetic, a liquid-liquid system comprising an aqueous layer and an oil layer and a liquid-solid system comprising an aqueous layer and powder such as carmine (calamine) lotion are often used. Are known. It has long been proposed to mix alcohols, surfactants and the like as essential components in two-layer cosmetics in order to improve their functions. For example, sodium pyrrolidonecarboxylate, ethyl alcohol and / or propyl alcohol, a multi-layer cosmetic containing a surfactant (Japanese Patent Publication No. 52-28851), sodium lactate, ethyl alcohol and / or propyl alcohol, and a surfactant were contained. Multilayer cosmetics (JP-A-54-41335),
Multilayer type liquid cosmetics containing surfactants, oils, water-soluble salts or organic acids, lower alcohols, and water (JP-A-64-40)
413), discloses an emulsified layer (Japanese Patent Laid-Open No. 4-112811) containing an oil agent and a nonionic surfactant which are liquid at ordinary temperature, and the upper layer of which is an emulsified layer.
【0003】しかしながら、エタノールは塗布後のさっ
ぱり感、清涼感は得られるものの、人によって皮膚に刺
激を感じる場合があり、不安を抱く消費者も多い。界面
活性剤としては、従来よりソルビタン脂肪酸エステル、
ポリオキシエチレンソルビタン脂肪酸エステル、ポリオ
キシエチレンアルキルエーテル、ポリグリセリンアルキ
ルフェニルエーテル、ポリオキシエチレンオレイルアル
コールエーテル、ポリオキシエチレン硬化ヒマシ油、ア
ルキルリン酸エステル塩、ポリオキシエチレンアルキル
エーテルリン酸、ポリオキシエチレンアルキルエーテル
リン酸塩、ポリオキシエチレングリコール脂肪酸エステ
ル、ポリオキシエチレン脂肪酸グリセリル、ポリオキシ
エチレンソルビット脂肪酸エステル等を用いた多層型化
粧料は広く知られているが、配合量が多く、べたつきが
あり、使用感に好ましくないという問題があった。ま
た、振とうして使用した後の分離に長時間を要したり、
分離後油層が透明にならなかったり、水層、油層の界面
に乳化物が現れたりして外観上好ましくないという欠点
があり、化粧料としての評価は低かった。[0003] However, although ethanol can provide a refreshing feeling and a refreshing feeling after application, some people may feel irritation to the skin, and many consumers have anxiety. As a surfactant, sorbitan fatty acid esters,
Polyoxyethylene sorbitan fatty acid ester, polyoxyethylene alkyl ether, polyglycerin alkylphenyl ether, polyoxyethylene oleyl alcohol ether, polyoxyethylene hydrogenated castor oil, alkyl phosphate ester salt, polyoxyethylene alkyl ether phosphate, polyoxyethylene Multilayer cosmetics using alkyl ether phosphate, polyoxyethylene glycol fatty acid ester, polyoxyethylene fatty acid glyceryl, polyoxyethylene sorbite fatty acid ester, etc. are widely known, but have a large blending amount and are sticky, There was a problem that the feeling of use was unfavorable. Also, it takes a long time to separate after shaking,
There were drawbacks that the oil layer did not become transparent after separation or an emulsion appeared at the interface between the aqueous layer and the oil layer, which was unfavorable in appearance, and was poorly evaluated as a cosmetic.
【0004】さらに、アルコールを必須成分としない多
層型化粧料も幾つか開示されているが、ポリグリセリン
アルキルフェニルエーテル型化合物、水溶性塩類、液状
油性物質、水(特開昭63−27409)は、分離後の
水層、油層の透明性や、水層と油層の界面の明瞭さは優
れているものの、化粧料として外用した場合に皮膚刺激
を与えることがあった。[0004] Further, some multilayer cosmetics not containing alcohol as an essential component have been disclosed, but polyglycerin alkylphenyl ether type compounds, water-soluble salts, liquid oily substances, and water (JP-A-63-27409) are disclosed. Although the transparency of the water layer and the oil layer after separation and the clarity of the interface between the water layer and the oil layer are excellent, skin irritation may occur when used externally as a cosmetic.
【0005】さらには、有機酸塩、多価アルコール、界
面活性剤、水等を含有した多層型化粧料として(特開昭
63−33317)、(特開昭63−79806)、
(特開昭63−79807)、(特開昭63−7980
8)、(特開昭63−79811)、(特開昭63−8
3009)、(特開昭63−83011)、(特開昭6
3−165304)、(特開昭63−165305)が
開示されているが、界面活性剤の使用割合が高く、安全
性と使用時の実用性を兼ね備えた多層型化粧料は得られ
ていない。Further, multilayer cosmetics containing organic acid salts, polyhydric alcohols, surfactants, water and the like (JP-A-63-33317), (JP-A-63-79806),
(JP-A-63-79807), (JP-A-63-7980)
8), (JP-A-63-79811), (JP-A-63-8798)
3009), (Japanese Patent Application Laid-Open No. 63-83011), and
3-165304) and (Japanese Patent Application Laid-Open No. 63-165305), however, a multi-layered cosmetic composition having a high use ratio of a surfactant and having both safety and practicality in use has not been obtained.
【0006】[0006]
【発明が解決しようとする課題】そこで、本発明におい
ては、上記のような従来の多層型化粧料の有する問題点
を解決し、皮膚に優れた感触を与え、二層分離性に優
れ、かつエタノール、イソプロピルアルコール等の低級
アルコールを含有しない水層と油層からなる、液−液系
タイプの二層型化粧料を提供することにある。Accordingly, the present invention solves the above-mentioned problems of the conventional multi-layer cosmetics, gives the skin an excellent feel, has excellent two-layer separability, and An object of the present invention is to provide a liquid-liquid type two-layer cosmetic comprising a water layer and an oil layer which do not contain a lower alcohol such as ethanol and isopropyl alcohol.
【0007】[0007]
【課題を解決するための手段】本発明者等は上記課題を
解決するために鋭意検討を行った結果、ポリオキシエチ
レンソルビタン脂肪酸エステル、及びソルビタン脂肪酸
エステルの一種又は二種以上の特定量と、クエン酸ナト
リウム特定量、及び水溶性高分子の一種又は二種以上の
特定量とを規定の範囲で配合すると、静置しておくと水
層と油層の二層に明確に分離するという外観及び使用時
に軽く振とうすると二層が容易に混ざり合い、乳液状と
なって、皮膚に極めて良好な感触を与える二層型化粧料
を得た。さらに、銅クロロフィルを特定量配合すること
により使用性が格段に向上することを見出し、本発明を
完成するに至った。Means for Solving the Problems The present inventors have conducted intensive studies in order to solve the above-mentioned problems, and as a result, polyoxyethylene sorbitan fatty acid ester, and one or more specific amounts of sorbitan fatty acid ester, When the specific amount of sodium citrate and the specific amount of one or more water-soluble polymers are blended in the prescribed range, the appearance and clear separation into two layers of an aqueous layer and an oil layer when left standing. When lightly shaken at the time of use, the two layers are easily mixed and become a milky liquid, thereby obtaining a two-layer cosmetic which gives the skin a very good feel. Furthermore, it has been found that the usability is remarkably improved by adding a specific amount of copper chlorophyll, and the present invention has been completed.
【0008】[0008]
【発明の実施の形態】以下、本発明の実施の形態につい
て詳述する。Embodiments of the present invention will be described below in detail.
【0009】本発明の二層型化粧料とは、水層と油層の
二層からなる液−液系タイプの化粧料で使用前の静置時
は水層と油層が明確に二層分離する外観で、使用直前に
軽く振とうし乳液状として使用する化粧料をいい、化粧
品や医薬部外品等、皮膚化粧料及び毛髪化粧料に適応で
きる。[0009] The two-layer cosmetic of the present invention is a liquid-liquid type cosmetic comprising two layers of an aqueous layer and an oil layer. When left at rest before use, the aqueous layer and the oil layer are clearly separated into two layers. Appearance, refers to cosmetics that are used by shaking lightly immediately before use as an emulsion, and can be applied to cosmetics, quasi-drugs, skin cosmetics, and hair cosmetics.
【0010】本発明で用いられる成分(A)ポリオキシ
エチレンソルビタン脂肪酸エステルとしては、モノヤシ
油脂肪酸POE(20)ソルビタン、モノパルミチン酸P
OE(20)ソルビタン、モノステアリン酸POE(20)
ソルビタン、モノステアリン酸POE(6)ソルビタ
ン、モノオレイン酸POE(20)ソルビタン、トリオレ
イン酸POE(20)ソルビタン、モノオレイン酸POE
(6)ソルビタン、モノイソステアリン酸POE(20)
ソルビタンが挙げられる。As the component (A) polyoxyethylene sorbitan fatty acid ester used in the present invention, mono-coconut fatty acid POE (20) sorbitan, monopalmitic acid P
OE (20) Sorbitan, POE monostearate (20)
Sorbitan, POE monostearate (6) sorbitan, POE monooleate (20) sorbitan, POE trioleate (20) sorbitan, POE monooleate
(6) Sorbitan, POE monoisostearate (20)
Sorbitan.
【0011】ソルビタン脂肪酸エステルとしては、モノ
ラウリン酸ソルビタン、モノパルミチン酸ソルビタン、
モノステアリン酸ソルビタン、セスキステアリン酸ソル
ビタン、トリステアリン酸ソルビタン、モノオレイン酸
ソルビタン、トリオレイン酸ソルビタン、モノイソステ
アリン酸ソルビタン、セスキイソステアリン酸ソルビタ
ンが挙げられ、使用前の振とう時の水層と油層の乳化
性、使用性、及び使用後静置した時の二層分離性よりポ
リオキスエチレンソルビタン脂肪酸エステルは、特にト
リオレイン酸POE(20)ソルビタンが好ましく、ソル
ビタン脂肪酸エステルは、特にセスキオレイン酸ソルビ
タンが好ましい。The sorbitan fatty acid esters include sorbitan monolaurate, sorbitan monopalmitate,
Sorbitan monostearate, sorbitan sesquistearate, sorbitan tristearate, sorbitan monooleate, sorbitan trioleate, sorbitan monoisostearate, and sorbitan sesquiisostearate. Polyoxethylene sorbitan fatty acid ester is particularly preferably POE (20) sorbitan trioleate, and sorbitan fatty acid ester is particularly sorbitan sesquioleate from the viewpoint of emulsifiability, usability, and two-layer separability upon standing after use. preferable.
【0012】成分(A)のポリオキシエチレンソルビタ
ン脂肪酸エステル及びソルビタン脂肪酸エステルは、一
種又は二種以上組合せて用いることができ、全組成中に
0.01重量%〜0.4重量%が好ましく、さらに好ま
しくは0.02〜0.3重量%で、この配合量が0.0
1重量%未満では、使用時に軽く振とうした時の乳化力
が弱く使用性に問題があり、逆に0.4重量%を越える
と、振とうして使用し、静置したとき油層が乳化した
り、水層と油層の界面に乳化物が生じ二層型化粧料とし
ての外観、安定性に問題がある。また、使用性において
べたつきが生じてしまう。The polyoxyethylene sorbitan fatty acid ester and the sorbitan fatty acid ester of the component (A) can be used alone or in combination of two or more, preferably 0.01 to 0.4% by weight in the total composition. More preferably, the content is 0.02 to 0.3% by weight,
If the amount is less than 1% by weight, the emulsifying power when lightly shaken during use is weak and there is a problem in useability. Conversely, if it exceeds 0.4% by weight, the oil layer is emulsified when used with shaking and allowed to stand. Or an emulsion is formed at the interface between the water layer and the oil layer, and there is a problem in appearance and stability as a two-layer cosmetic. In addition, stickiness occurs in usability.
【0013】本発明で用いられる成分(B)クエン酸ナ
トリウムとしては、全組成中0.5〜2.5重量%が好
ましく、さらに好ましくは0.7〜1.5重量%であ
る。この配合量が0.5重量%未満では、振とうして使
用し、静置したとき水層と油層の界面に乳化物が生じ、
または水層と油層が乳化する問題がある。逆に2.5重
量%を越えると使用性においてべたつきが生じてしま
う。The component (B) sodium citrate used in the present invention is preferably from 0.5 to 2.5% by weight, more preferably from 0.7 to 1.5% by weight, based on the total composition. When the blending amount is less than 0.5% by weight, the emulsion is used at the interface between the water layer and the oil layer when used with shaking and allowed to stand,
Alternatively, there is a problem that the water layer and the oil layer are emulsified. Conversely, if it exceeds 2.5% by weight, stickiness occurs in usability.
【0014】本発明で用いられる成分(C)水溶性高分
子としては、キサンタンガム及び/又はヒアルロン酸ナ
トリウムが挙げられる。キサンタンガムは主鎖がグルコ
ース2残基からなり、側鎖はマンノース2残基と1残基
のグルクロン酸を構成単位とする繰り返し構造からなる
多糖類を用い、これらと架橋構造、高次構造が異ならな
ければ、化粧料一般に使用されているものを配合でき
る。The component (C) water-soluble polymer used in the present invention includes xanthan gum and / or sodium hyaluronate. Xanthan gum uses a polysaccharide whose main chain consists of two residues of glucose, and whose side chain has a repeating structure consisting of two residues of mannose and one residue of glucuronic acid. If not, cosmetics commonly used can be blended.
【0015】ヒアルロン酸ナトリウムは、乳酸菌の一種
であるStreptococcus zooepidemicusを用いる発酵法又
は培養法により得られる分子量5万〜220万のもので
ある。キサンタンガムは化粧料や食品等の増粘や安定剤
として使用することはよく知られ、化粧料では美白剤の
水溶性ビタミンCを配合した化粧料の増粘剤、安定剤と
しても好んで使用されることもよく知られている。ま
た、ヒアルロン酸ナトリウムは保湿剤としてよく知られ
ている。[0015] Sodium hyaluronate has a molecular weight of 50,000 to 2.2 million obtained by a fermentation method or a culture method using Streptococcus zooepidemicus, a kind of lactic acid bacteria. It is well known that xanthan gum is used as a thickener and stabilizer for cosmetics and foods. In cosmetics, water-soluble vitamin C, a whitening agent, is used as a thickener and stabilizer for cosmetics. It is also well known that Also, sodium hyaluronate is well known as a humectant.
【0016】しかしながら、本発明に用いられるキサン
タンガム及び/又はヒアルロン酸ナトリウムの配合は、
振とうし、使用している間の乳化安定性を決定づけるも
ので、水層と油層の分離スピードを調整して使用性、使
い易さを高めるために用いる。このようなキサンタンガ
ムの配合量は、全組成中0.01〜0.3重量%が好ま
しく、さらに好ましくは0.05〜0.15重量%であ
る。この配合量が0.01重量%未満では、軽く振とう
して使用するとき、水層と油層の分離スピードが速すぎ
使用性、使い易さに問題がある。逆に0.3重量%を越
えると使用性にべたつきが生じてしまう。However, the composition of xanthan gum and / or sodium hyaluronate used in the present invention is as follows:
Shake and determine the emulsion stability during use. It is used to adjust the separation speed of the aqueous layer and the oil layer to enhance usability and ease of use. The amount of such xanthan gum is preferably 0.01 to 0.3% by weight, more preferably 0.05 to 0.15% by weight, based on the total composition. When the amount is less than 0.01% by weight, the separation speed of the water layer and the oil layer is too high when used with gentle shaking, and there is a problem in usability and ease of use. Conversely, if it exceeds 0.3% by weight, stickiness occurs in the usability.
【0017】ヒアルロン酸ナトリウムの配合量は、全量
に対して0.005〜0.15重量%が好ましく、さら
に好ましくは0.01〜0.075重量%である。この
配合量が0.005重量%未満では、軽く振とうして使
用するとき、水層と油層の分離スピードが速すぎ、使用
性、使い易さに問題がある。逆に0.15重量%を越え
ると使用性においてべたつきが生じてしまう。The amount of sodium hyaluronate is preferably 0.005 to 0.15% by weight, more preferably 0.01 to 0.075% by weight, based on the total amount. When the amount is less than 0.005% by weight, the separation speed of the water layer and the oil layer is too high when used with gentle shaking, and there is a problem in usability and ease of use. Conversely, if it exceeds 0.15% by weight, stickiness occurs in usability.
【0018】銅クロロフィルは油溶性色素で、本発明で
は上層の油層に配合して適度な緑色に着色し、水層とコ
ントラストをつけて消費者に二層分離の状態を示すもの
である。消費者が最初から最後まで水層と油層の配合バ
ランスを崩さないで使用するために、使用前によく振と
うして皮膚に塗布する必要があるという、その必要性を
視覚的に示すものである。よって、本発明は油層で極め
て安定な油溶性緑色色素の銅クロロフィルを配合する。Copper chlorophyll is an oil-soluble pigment. In the present invention, it is blended with the upper oil layer and colored in an appropriate green color, giving a contrast with the aqueous layer to show the state of two-layer separation to the consumer. It is a visual indication of the necessity that consumers must apply the product to the skin by shaking well before use in order to use the composition from the beginning to the end without breaking the balance between the water layer and the oil layer. is there. Therefore, the present invention incorporates an oil-soluble green pigment, copper chlorophyll, which is extremely stable in the oil layer.
【0019】この銅クロロフィルの配合量は全組成中
0.0001〜0.02重量%が好ましく、さらに好ま
しくは0.0005〜0.01重量%で、この配合量が
0.0001重量%未満では色調が弱く、0.02重量
%を越えると均一に溶解せず、解け残りや沈殿を生ずる
ことがある。The content of the copper chlorophyll is preferably 0.0001 to 0.02% by weight, more preferably 0.0005 to 0.01% by weight, based on the total composition, and if the content is less than 0.0001% by weight. If the color tone is weak, if it exceeds 0.02% by weight, it will not be uniformly dissolved, and unmelting or precipitation may occur.
【0020】本発明の二層型化粧料には上気した必須構
成成分の他に、通常の化粧品、医薬部外品、医薬品等の
皮膚外用剤に用いられる成分、例えば油脂、炭化水素
油、エステル類、保湿剤、多価アルコール、水溶性塩
類、抗炎症剤、防腐剤、酸化防止剤、中和剤、キレート
剤、薬剤、シリコーン油、精油、色素、香料、精製水等
を必要に応じて適宜配合することができる。以下に配合
可能な成分の具体例を列挙するが、本発明の二層型化粧
料は、これら成分の任意の一種又は二種以上を上記必須
成分と配合して常法により製造することができる。In the two-layer cosmetic of the present invention, in addition to the essential components which have been mentioned above, components used in external skin preparations such as ordinary cosmetics, quasi-drugs, and pharmaceuticals, such as oils and fats, hydrocarbon oils, Esters, humectants, polyhydric alcohols, water-soluble salts, anti-inflammatory agents, preservatives, antioxidants, neutralizers, chelating agents, drugs, silicone oils, essential oils, pigments, flavors, purified water, etc. as required Can be appropriately blended. Specific examples of components that can be blended are listed below, but the two-layer cosmetic of the present invention can be manufactured by a conventional method by blending any one or more of these components with the above essential components. .
【0021】油脂としては、例えばマカデミアナッツ
油、月見草油、ヒマワリ油、ローズヒップ油、エゴマ
油、トウモロコシ油、オリーブ油、ゴマ油、コムギ胚芽
油、ブドウ種子油、アボガド油、サフラワー油、スイー
トアルモンド油、ヘーゼルナッツ油、卵黄油、ヒドロキ
システアリン酸コレステリル、マカデミアナッツ油脂肪
酸コレステリル等が挙げられる。Examples of fats and oils include macadamia nut oil, evening primrose oil, sunflower oil, rosehip oil, perilla oil, corn oil, olive oil, sesame oil, wheat germ oil, grape seed oil, avocado oil, safflower oil, sweet almond oil, Examples include hazelnut oil, egg yolk oil, cholesteryl hydroxystearate, and cholesteryl fatty acid macadamia nut oil.
【0022】炭化水素油として、例えば流動パラフィ
ン、オリーブスクワラン、スクワラン、プリスタン等が
挙げられる。Examples of the hydrocarbon oil include liquid paraffin, olive squalane, squalane, pristane and the like.
【0023】エステル類として、例えばイソノナン酸イ
ソノニル、イソノナン酸イソトリデシル、オクタン酸イ
ソセチル、ミリスチン酸イソステアリル、ジオクタン酸
ネオペンチルグリコール、ジカプリン酸ネオペンチルグ
リコール、トリ2−エチルヘキサン酸グリセリル、トリ
(カプリル・カプリン酸)グリセリル、トリイソステア
リン酸トリメチロールプロパン、乳酸オクチルドデシ
ル、リンゴ酸ジイソステアリル、イソステアリン酸イソ
ステアリル、イソステアリン酸イソセチル、イソステア
リン酸イソプロピル、イソステアリン酸オクチルドデシ
ル、イソパルミチン酸オクチル、イソペラルゴン酸オク
チル、2−エチルヘキサン酸セチル、ラウリン酸ヘキシ
ル、ジメチルオクタン酸オクチルドデシル等が挙げられ
る。これら油脂、炭化水素油、エステル類等の油性成分
は、1〜50重量%の範囲で配合できる。As esters, for example, isononyl isononanoate, isotridecyl isononanoate, isocetyl octoate, isostearyl myristate, neopentyl glycol dioctanoate, neopentyl glycol dicaprate, glyceryl tri-2-ethylhexanoate, tri (caprylic caprin) Acids) glyceryl, trimethylolpropane triisostearate, octyldodecyl lactate, diisostearyl malate, isostearyl isostearate, isocetyl isostearate, isopropyl isostearate, octyldodecyl isostearate, octyl isopalmitate, octyl isoperargonate, 2 -Cetyl ethylhexanoate, hexyl laurate, octyldodecyl dimethyloctanoate and the like. These oily components such as fats, hydrocarbon oils and esters can be blended in the range of 1 to 50% by weight.
【0024】保湿剤としては、通常、化粧料に保湿剤と
して使用されている成分であればいずれも使用できる
が、例えばヒアルロン酸等のムコ多糖類、キシロビオー
ス混合物、ポリアクリル酸ナトリウム、トリメチルグリ
シン、ピロリドンカルボン酸ナトリウム、サクシニルカ
ルボキシメチルキトサン、サクシニルキトサン等が挙げ
られる。As the humectant, any components which are usually used as humectants in cosmetics can be used. For example, mucopolysaccharides such as hyaluronic acid, xylobiose mixture, sodium polyacrylate, trimethylglycine, Examples include sodium pyrrolidonecarboxylate, succinylcarboxymethylchitosan, and succinylchitosan.
【0025】多価アルコールとしては、例えばエチレン
グリコール、ポリエチレングリコール、プロピレングリ
コール、1,3−ブチレングリコール、ジプロピレング
リコール、グリセリン、ジグリセリン、ポリグリセリ
ン、グリコース、マルトース、マルチトース、キシリト
ース、ソルビトール、エリスリトール、3−メチル−
1,3−ブタンジオール等が挙げられる。Examples of the polyhydric alcohol include ethylene glycol, polyethylene glycol, propylene glycol, 1,3-butylene glycol, dipropylene glycol, glycerin, diglycerin, polyglycerin, glycose, maltose, maltose, xylitol, sorbitol, erythritol, 3-methyl-
1,3-butanediol and the like.
【0026】水溶性塩類としては、無機塩、有機酸塩を
用いることができ、例えば塩化ナトリウム、塩化カリウ
ム、硫酸ナトリウム、硫酸マグネシウム、炭酸ナトリウ
ム、炭酸カルシウム、亜硫酸ナトリウム、乳酸ナトリウ
ム、リン酸水素ナトリウム、リン酸水素二ナトリウム、
クエン酸、リンゴ酸、コハク酸、酒石酸等が挙げられ
る。As the water-soluble salts, inorganic salts and organic acid salts can be used. For example, sodium chloride, potassium chloride, sodium sulfate, magnesium sulfate, sodium carbonate, calcium carbonate, sodium sulfite, sodium lactate, sodium hydrogen phosphate , Disodium hydrogen phosphate,
Citric acid, malic acid, succinic acid, tartaric acid and the like.
【0027】抗炎症剤としては、通常、化粧料に抗炎症
剤として使用されている成分であればいずれも使用でき
るが、例えばコンフリーエキス、シナノキエキス、ボタ
ンエキス、ゲンチアナエキス、ユキノシタエキス、ビサ
ボロール、マロニエエキス、グリチルリチン酸塩類、ア
ラントイン等が挙げられる。As the anti-inflammatory agent, any components which are usually used as an anti-inflammatory agent in cosmetics can be used. For example, comfrey extract, linden extract, button extract, gentian extract, saxifrage extract, bisabolol , Maronier extract, glycyrrhizinates, allantoin and the like.
【0028】パラベン、1,2ペンタンジオール、フェ
ノキシエタノール、感光素201号等の防腐剤、天然ビタ
ミンE、トコフェノール等の酸化防止剤、クエン酸、ア
ルギニン、アミノメチルプロパンジオール等の中和剤、
ヒドロキシエタンジホスホン酸四ナトリウム、エデト酸
塩類等のキレート剤、ビタミンA及び誘導体、ビタミン
B6塩酸塩、ビタミンB2及びその誘導体、ビタミンB
12、ビタミンB15及びその誘導体等のビタミンB類、ア
スコルビン酸リン酸エステル(塩)等のビタミンC類、
α−トコフェロール、β−トコフエロール、γ−トコフ
ェロール、ビタミンEアセテート等のビタミンE類、ビ
タミンD類、ビタミンH、パントテン酸、パントテチン
酸等のビタミン類、プラセンタエキス、セラミド、バイ
オセラミド、ビフィズス菌エキス等の薬剤、メチルフェ
ニルポリシロキサン等のシリコーン油、ラベンダー油、
ローマカミツレ油等の精油、さらに、クチナシ青、銅ク
ロロフィリンナトリウム等の色素等がそれぞれ挙げられ
る。Preservatives such as paraben, 1,2 pentanediol, phenoxyethanol, and photosensitizer 201; antioxidants such as natural vitamin E and tocophenol; neutralizing agents such as citric acid, arginine and aminomethylpropanediol;
Hidorokishietanjihosuhon tetrasodium, chelating agents such as edetic acid salts, vitamin A and derivatives, vitamin B 6 hydrochloride, vitamin B 2 and its derivatives, vitamin B
12 , vitamin B such as vitamin B 15 and its derivatives, vitamin C such as ascorbic acid phosphate (salt),
Vitamin E such as α-tocopherol, β-tocopherol, γ-tocopherol, vitamin E acetate, vitamin D, vitamin H, pantothenic acid, vitamin such as pantothenic acid, placenta extract, ceramide, bioceramide, bifidobacterium extract, etc. Drugs, silicone oils such as methylphenylpolysiloxane, lavender oil,
Essential oils such as Roman chamomile oil, and pigments such as gardenia blue and sodium copper chlorophyllin are also included.
【0029】本発明の二層型化粧料は、例えば化粧品、
医薬部外品分野において、皮膚化粧料、毛髪化粧料等と
して利用される。The two-layer cosmetic of the present invention is, for example, a cosmetic,
In the field of quasi-drugs, it is used as skin cosmetics, hair cosmetics and the like.
【0030】[0030]
【実施例】つぎに、本発明の実施例及び比較例により更
に詳細に説明するが、本発明はこれらにより何ら限定さ
れるものではない。なお、配合量は重量%である。「表
1」〜「表3」の処方によって、常法により二層型化粧
料を調整し、その二層分離した水層と油層を軽く振とう
した時の乳化性と使い易さ、静置した時の分離スピード
と二層分離性、及び使用感について評価した。得られた
結果を「表1」〜「表3」に併せて記す。Next, the present invention will be described in more detail with reference to Examples and Comparative Examples, but the present invention is not limited thereto. In addition, the compounding amount is weight%. A two-layer cosmetic is prepared according to the formulas in Tables 1 to 3 by a conventional method, and the water layer and the oil layer separated from the two layers are emulsified, easily used, and allowed to stand when lightly shaken. Then, the separation speed, the two-layer separation property, and the feeling upon use were evaluated. The obtained results are also shown in “Table 1” to “Table 3”.
【0031】振とう時の乳化性と使い易さ、静置した時
の分離スピードと二層分離性、使用感の評価方法、評価
基準は次のとおりである。The emulsifying properties and ease of use during shaking, the separation speed and the two-layer separability when allowed to stand, the method of evaluating the feeling of use, and the evaluation criteria are as follows.
【0032】〔振とう時の乳化性と使い易さ〕パネラー
(10名)により、以下の評価基準に基いて振とう時の
乳化性と使い易さの評価を行った。 ◎ 10名中8名以上が乳化性が良好で使い易いと回答
した。 ○ 10名中6名以上が乳化性が良好で使い易いと回答
した。 △ 10名中4名以上が乳化性が良好で使い易いと回答
した。 × 10名中4名未満が乳化性が良好で使い易いと回答
した。[Emulsification and Ease of Use During Shaking] The emulsification and ease of use during shaking were evaluated by panelists (10 persons) based on the following evaluation criteria. 8 Eight or more of the ten respondents answered that the emulsifiability was good and easy to use. ○ Six or more of the ten respondents answered that the emulsifiability was good and easy to use. B: Four or more out of 10 answered that the emulsifiability was good and easy to use. × Less than 4 out of 10 answered that the emulsifiability was good and easy to use.
【0033】〔使用感〕パネラー(10名)により、以
下の評価基準に基いて使用感の評価を行った。 「べたつき」 ◎ 10名中8名以上がべたつかないと回答した。 ○ 10名中6名以上がべたつかないと回答した。 △ 10名中4名以上がべたつかないと回答した。 × 10名中4名未満がべたつかないと回答した。 「肌への違和感」 ◎ 10名中8名以上が違和感はないと回答した。 ○ 10名中6名以上が違和感はないと回答した。 △ 10名中4名以上が違和感はないと回答した。 × 10名中4名未満が違和感はないと回答した。[Feeling of use] The feeling of use was evaluated by panelists (10 persons) based on the following evaluation criteria. "Stickiness" ◎ More than 8 out of 10 responded that they were not sticky. ○ Six or more respondents answered that they were not sticky. △ At least 4 out of 10 responded that they were not sticky. × Less than 4 out of 10 responded that they were not sticky. “Skin discomfort” ◎ More than 8 out of 10 responded that there was no discomfort. ○ More than 6 out of 10 responded that there was no discomfort. △ At least 4 out of 10 responded that there was no discomfort. × Less than 4 out of 10 respondents did not feel uncomfortable.
【0034】〔静置後の分離状態の確認具合と二層分離
性〕パネラー(10名)により、以下の評価基準に基い
て二層分離性の評価を行った。 ◎ 10名中8名以上が綺麗に分離すると回答した。 ○ 10名中6名以上が綺麗に分離すると回答した。 △ 10名中4名以上が綺麗に分離すると回答した。 × 10名中4名未満が綺麗に分離すると回答した。[Confirmation of separation state after standing and two-layer separation property] Two-layer separation property was evaluated by panelists (10 persons) based on the following evaluation criteria. ◎ Eight or more of the ten respondents answered that they were cleanly separated. ○ More than 6 out of 10 respondents answered that they were cleanly separated. △ 4 or more of 10 respondents answered that they were cleanly separated. × Less than 4 out of 10 responded that they separated cleanly.
【0035】実施例1〜3及び比較例1〜3 美容液 表1に示す組成の美容液を調製し、上記評価方法及び判
定方法により、振とう時の乳化性と使い易さ、使用感、
静置後の分離状態の確認具合と二層分離性について評価
を行った。得られた結果を表1に併せて記す。Examples 1 to 3 and Comparative Examples 1 to 3 Essences Essences having the composition shown in Table 1 were prepared, and emulsifying properties upon shaking, ease of use, feeling of use,
The degree of confirmation of the separation state after standing and the two-layer separation property were evaluated. The obtained results are also shown in Table 1.
【0036】[0036]
【表1】 [Table 1]
【0037】〔製法〕水相、油相それぞれを予め均質に
混合し、油相を水相に添加して均質に混合して美容液を
調製した。[Preparation Method] The aqueous phase and the oil phase were previously homogeneously mixed, and the oil phase was added to the aqueous phase and mixed homogeneously to prepare a serum.
【0038】表1から明らかなように、本発明の美容液
は、比較例1〜3のものと比較して、振とう時の乳化性
及び使い易さ、使用感、静置後の二層分離性において良
好な結果を示し、優れた美容液が得られた。また、表1
から明らかなように、銅クロロフィルを0.0001か
ら0.02重量%を配合すると分離状態が確認し易く使
い易いことがわかる。As is clear from Table 1, the cosmetic serum of the present invention is more emulsifying and easier to use when shaking than that of Comparative Examples 1 to 3, the feeling of use, and the two layers after standing. Good results were obtained in the separability, and an excellent serum was obtained. Table 1
As is clear from the above, when 0.0001 to 0.02% by weight of copper chlorophyll is blended, the separated state is easily confirmed and it is easy to use.
【0039】実施例4及び比較例4〜8 ボデイロー
ション 表2に示す組成のボデイローションを調製し、上記評価
方法及び判定方法により、振とう時の乳化性と使い易
さ、使用感、放置後の分離状態の確認具合と二層分離性
について評価を行った。得られた結果を表2に併せて記
す。Example 4 and Comparative Examples 4 to 8 Body lotions Body lotions having the compositions shown in Table 2 were prepared, and emulsifying properties upon shaking, ease of use, feeling of use, and after standing by the above evaluation method and judgment method. Was evaluated for the degree of confirmation of the separation state and the two-layer separation property. The obtained results are also shown in Table 2.
【0040】[0040]
【表2】 [Table 2]
【0041】〔製法〕水相、油相それぞれを予め均質に
混合し、油相を相層に添加して均質に混合してボデイロ
ーションを調製した。[Production Method] A water lotion and an oil phase were previously mixed homogeneously, and the oil phase was added to the phase layer and mixed homogeneously to prepare a body lotion.
【0042】表2から明らかなように、クエン酸ナトリ
ウムの配合量が0.5重量%未満では静置後の二層分離
性が不十分であり、2.5重量%以上では肌がべたつ
き、違和感があり使用感が劣る。また、セスキオレイン
酸ソルビタン、トリオレイン酸POE(20)ソルビタン
の配合量が0.01重量%未満では振とう時の乳化力が
弱く使用性に劣り、0.4重量%以上では静置後の二層
分離性が悪い。As is clear from Table 2, if the amount of sodium citrate is less than 0.5% by weight, the two-layer separation property after standing is insufficient, and if it is more than 2.5% by weight, the skin becomes sticky. There is a sense of incongruity and the usability is poor. When the amount of sorbitan sesquioleate or POE (20) sorbitan trioleate is less than 0.01% by weight, the emulsifying power at the time of shaking is weak and the usability is poor. Poor two-layer separation.
【0043】実施例5〜6及び比較例9〜10 養毛
料 表3に示す組成の養毛料を調製し、上記評価方法及び判
定方法により、振とう時の乳化性と使い易さ、使用感、
静置後の分離状態の確認具合と二層分離性について評価
を行った。得られた結果を表3に併せて記す。Examples 5 to 6 and Comparative Examples 9 to 10 Hair restorer A hair restorer having the composition shown in Table 3 was prepared, and emulsifiability during shaking, ease of use, feeling of use,
The degree of confirmation of the separation state after standing and the two-layer separation property were evaluated. The results obtained are also shown in Table 3.
【0044】[0044]
【表3】 [Table 3]
【0045】〔製法〕水相、油相それぞれを予め均質に
混合し、油相を水相に添加して均質に混合して養毛料を
調製した。[Production Method] Each of the aqueous phase and the oil phase was previously homogeneously mixed, and the oil phase was added to the aqueous phase and mixed homogeneously to prepare a hair restorer.
【0046】表3から明らかなように、キサンタンガム
の配合量が0.01重量%未満では分離スピードが速
く、使い易さに劣り、0.3重量%以上ではべたつき、
違和感がある。As is clear from Table 3, when the amount of xanthan gum is less than 0.01% by weight, the separation speed is high and the ease of use is inferior.
There is a sense of discomfort.
【0047】[0047]
【発明の効果】以上詳述した如く、本発明の二層型化粧
料は、使用前の再乳化性、使用後の二層分離性に優れた
二層型の綺麗な外観を呈する液体の化粧料で、優れた使
用感が得られるものである。As described in detail above, the two-layer cosmetic of the present invention is a two-layer liquid cosmetic exhibiting excellent re-emulsifiability before use and excellent two-layer separability after use. The material gives an excellent feeling of use.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 森 俊晴 静岡県志太郡岡部町入野65−1 日興製薬 株式会社岡部工場内 Fターム(参考) 4C083 AA032 AA072 AA112 AA122 AC022 AC122 AC301 AC302 AC402 AC441 AC442 AC482 AC931 AC932 AD152 AD332 AD352 BB36 CC01 CC05 CC23 CC37 DD05 EE06 EE07 ──────────────────────────────────────────────────の Continued on the front page (72) Inventor Toshiharu Mori 65-1 Irino, Okabe-cho, Shita-gun, Shizuoka Prefecture F-term in Okabe Plant, Nikko Pharmaceutical Co., Ltd. AC932 AD152 AD332 AD352 BB36 CC01 CC05 CC23 CC37 DD05 EE06 EE07
Claims (2)
肪酸エステル、及びソルビタン脂肪酸エステルの一種又
は二種以上と、(B)クエン酸ナトリウムと、(C)水
溶性高分子の一種又は二種以上を含有することを特徴と
する二層型化粧料。1. A composition comprising (A) one or more polyoxyethylene sorbitan fatty acid esters and sorbitan fatty acid esters, (B) sodium citrate, and (C) one or more water-soluble polymers. A two-layer cosmetic.
を特徴とする請求項1に記載の二層型化粧料。2. The two-layer cosmetic according to claim 1, further comprising copper chlorophyll.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP27220599A JP3492952B2 (en) | 1999-09-27 | 1999-09-27 | Liquid-liquid two-layer cosmetic consisting of water layer and oil layer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP27220599A JP3492952B2 (en) | 1999-09-27 | 1999-09-27 | Liquid-liquid two-layer cosmetic consisting of water layer and oil layer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001097841A true JP2001097841A (en) | 2001-04-10 |
| JP3492952B2 JP3492952B2 (en) | 2004-02-03 |
Family
ID=17510580
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP27220599A Expired - Fee Related JP3492952B2 (en) | 1999-09-27 | 1999-09-27 | Liquid-liquid two-layer cosmetic consisting of water layer and oil layer |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3492952B2 (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009161508A (en) * | 2007-04-17 | 2009-07-23 | Kao Corp | Hair cosmetics |
| US9713582B2 (en) | 2015-04-13 | 2017-07-25 | The Procter & Gamble Company | Multi-layered cosmetic composition |
| WO2020128555A1 (en) * | 2018-12-19 | 2020-06-25 | L V M H Recherche | Redispersible two-layer cosmetic |
| CN116440014A (en) * | 2023-04-10 | 2023-07-18 | 上海柒色生物科技有限公司 | Double-layer plant essential oil spray with mosquito repelling effect and preparation method thereof |
-
1999
- 1999-09-27 JP JP27220599A patent/JP3492952B2/en not_active Expired - Fee Related
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009161508A (en) * | 2007-04-17 | 2009-07-23 | Kao Corp | Hair cosmetics |
| US9011886B2 (en) | 2007-04-17 | 2015-04-21 | Kao Corporation | Hair cosmetic composition |
| US9713582B2 (en) | 2015-04-13 | 2017-07-25 | The Procter & Gamble Company | Multi-layered cosmetic composition |
| JP2018510885A (en) * | 2015-04-13 | 2018-04-19 | ザ プロクター アンド ギャンブル カンパニー | Multi-layer cosmetic composition |
| WO2020128555A1 (en) * | 2018-12-19 | 2020-06-25 | L V M H Recherche | Redispersible two-layer cosmetic |
| CN116440014A (en) * | 2023-04-10 | 2023-07-18 | 上海柒色生物科技有限公司 | Double-layer plant essential oil spray with mosquito repelling effect and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| JP3492952B2 (en) | 2004-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4527530B2 (en) | Vesicle dispersion and cosmetics containing the same | |
| KR102359729B1 (en) | Cosmetic Composition for Reducing Stickiness and Improving Transparency of Emulsion Formulation | |
| JPH06329532A (en) | Water-in-oil aerosol composition and production process thereof | |
| JP5043467B2 (en) | Topical skin preparation | |
| JP2009298748A (en) | Liquid crystal lamellar type composition for cosmetic and cosmetic containing the same | |
| JP5069965B2 (en) | Topical skin preparation | |
| KR20150044104A (en) | Makeup kit composition having double layer of makeup layer and moisture and shimmering layer after applying on skin | |
| JP2025083496A (en) | Cosmetic compositions comprising sucrose esters and solvents | |
| EP2617410A1 (en) | Oil-in-water type cosmetic | |
| WO2013021775A1 (en) | Liquid skin-conditioning composition | |
| JP6133618B2 (en) | Water-in-oil emulsion composition | |
| JP5165299B2 (en) | Topical skin preparation | |
| JP3975060B2 (en) | A liquid-liquid two-layer cosmetic comprising an aqueous layer and an oil layer | |
| JP4332062B2 (en) | Water-in-oil whitening cosmetic | |
| JP3492952B2 (en) | Liquid-liquid two-layer cosmetic consisting of water layer and oil layer | |
| JP2004307414A (en) | W/o/w emulsion skin care preparation for external use and method for producing the same | |
| JP2003081741A (en) | Skin care preparation | |
| JP2005247759A (en) | Oil-in-water-type emulsion fragrance composition and method for producing the same | |
| TW202308591A (en) | Cosmetic | |
| JP2001354510A (en) | Oil-in-water type composition for external use | |
| JP2007217338A (en) | Oil-in-water type emulsion composition | |
| JP2007161635A (en) | Two layer separating type cosmetic | |
| JP2002241211A (en) | Cosmetics | |
| JP2005179320A (en) | Oil-in-water emulsion composition | |
| US7252830B2 (en) | Moisturizing compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20031007 |
|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313532 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091114 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121114 Year of fee payment: 9 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131114 Year of fee payment: 10 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |